PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells

Clinical Oral Investigations

Volumn 15, Issue 6, 2011, Pages 941-952

  Lossdörfer, Stefan ^a   Götz, Werner ^a   Jäger, Andreas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Co culture of human PDL cells and RAW cells; In vitro; Intermittent PTH(1 34); Osteoclasts biology; Osteoprotegerin; RANKL

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; ISOENZYME; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; VITRONECTIN RECEPTOR;

ADOLESCENT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CHILD; COCULTURE; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; HOMEOSTASIS; HUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIODONTAL LIGAMENT; PHYSIOLOGY; REGENERATION;

ACID PHOSPHATASE; ADOLESCENT; BONE RESORPTION; CATHEPSIN K; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CHILD; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; HOMEOSTASIS; HUMANS; INTEGRIN ALPHAVBETA3; ISOENZYMES; OSTEOCLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE; PERIODONTAL LIGAMENT; RANK LIGAND; REGENERATION;

EID: 80955130003     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-010-0456-0     Document Type: Article

References (52)

1. Bostanci N, Ilgenli T, Emingil G et al (2007) Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 34: 370-376.
2. Nagasawa T, Kiji M, Yashiro R et al (2000) (2007) Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 43: 65-84.
3. Lu HK, Chen YL, Chang HC et al (2006) Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 41: 354-360.
4. Belibasakis G, Bostanci N, Hashim A et al (2007) Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. Microb Pathog 43: 46-53.
5. Yamamoto T, Kita M, Oseko F et al (2006) Cytokine production in human periodontal ligament cells stimulated with Porphyromonas gingivalis. J Periodontal Res 41: 554-559.
6. Lappin DF, Sherrabeh S, Jenkins WM et al (2007) Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. J Clin Periodontol 34: 271-277.
7. Nishijima Y, Yamaguchi M, Kojima T et al (2006) Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. Orthod Craniofac Res 9: 63-70.
8. Yamaguchi M, Aihara N, Kojima T et al (2006) RANKL increase in compressed periodontal ligament cells from root resorption. J Dent Res 85: 751-756.
9. Kanzaki H, Chiba M, Arai K et al (2006) Local RANKL gene transfer to the periodontal tissue accelerates orthodontic tooth movement. Gene Ther 13: 678-685.
10. Kanzaki H, Chiba M, Takahashi I et al (2004) Local OPG gene transfer to periodontal tissue inhibits orthodontic tooth movement. J Dent Res 83: 920-925.
11. Pinkerton MN, Wescott DC, Gaffey BJ et al (2008) Cultured human periodontal ligament cells constitutively express multiple osteotropic cytokines and growth factors, several of which are responsive to mechanical deformation. J Periodontal Res 43: 343-351.
12. Kanzaki H, Chiba M, Shimizu Y et al (2001) Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. J Dent Res 80: 887-891.
13. Lossdorfer S, Gotz W, Jager A (2005) PTH(1-34) affects osteoprotegerin production in human PDL cells in vitro. J Dent Res 84: 634-638.
14. Hasegawa T, Yoshimura Y, Kikuiri T et al (2002) Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodontal Res 37: 405-411.
15. Isaka J, Ohazama A, Kobayashi M et al (2001) Participation of periodontal ligament cells with regeneration of alveolar bone. J Periodontol 72: 314-323.
16. Chou AM, Sae-Lim V, Lim T et al (2002) Culturing and characterization of human periodontal ligament fibroblasts-a preliminary study. Mater Sci Eng 20: 77-83.
17. Basdra EK, Komposch G (1997) Osteoblast-like properties of human periodontal l igament cells: an in vitro analysis. Eur J Orthod 19: 615-621.
18. Fukushima H, Jimi E, Kajiya H et al (2005) Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway. J Dent Res 84: 329-334.
19. Zhang D, Yang YQ, Li XT et al (2004) The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha, 25-dihydroxyvitamin D3. Arch Oral Biol 49: 71-76.
20. Yang ZJ, Cheng V, Barnes S et al (1997) Pulsatile parathyroid hormone (PTH) treatment increases bone formation in vitro in fetal rat calvarial cell (FRCC) culture system. J Bone Miner Res 12(Suppl 1): S317.
21. Sone T, Fukunaga M, Ono S et al (1995) A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Miner Electrolyte Metab 21: 232-235.
22. Lossdorfer S, Gotz W, Jager A (2006) Parathyroid hormone modifies human periodontal ligament cell proliferation and survival in vitro. J Periodontal Res 41: 519-526.
23. Lossdorfer S, Stier S, Gotz W et al (2006) Maturation-state dependent response of human periodontal ligament cells to an intermittent parathyroid hormone exposure in vitro. J Periodontal Res 41: 62-72.
24. Bonewald LF, Harris SE, Rosser J et al (2003) Von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 72: 537-547.
25. Hayman AR, Jones SJ, Boyde A et al (1996) Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122: 3151-3162.
26. Inaoka T, Bilbe G, Ishibashi O et al (1995) Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206: 89-96.
27. Felding-Habermann B, Cheresh DA (1993) Vitronectin and its receptors. Curr Opin Cell Biol 5: 864-868.
28. Andrade I Jr, Taddei SR, Garlet GP et al (2009) CCR5 down-regulates osteoclast function in orthodontic tooth movement. J Dent Res 88: 1037-1041.
29. Lossdorfer S, Schwartz Z, Wang L et al (2004) Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. J Biomed Mater Res A 70: 361-369.
30. Kwan Tat S, Amiable N, Pelletier JP et al (2009) Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford) 48: 1482-1490.
31. Czupalla C, Mansukoski H, Pursche T et al (2005) Comparative study of protein and mRNA expression during osteoclastogenesis. Proteomics 5: 3868-3875.
32. Li X, Qin L, Bergenstock M et al (2007) Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem 282: 33098-33106.
33. Mozar A, Haren N, Chausseraud M et al (2008) High extracellular inorganic phosphate oncentration inhibits RANK-RANKL signaling in osteoclast-like cells. J Cell Physiol 215: 47-54.
34. Hsu H, Lacey D, Dunstan C et al (1999) Tumor necrosis factor receptor family member RANKL mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96: 3540-3545.
35. Suda T, Takahashi N, Martin T (1992) Modulation of osteoclast differentiation. Endocr Rev 13: 66-80.
36. Bianco P, Costantini M, Dearden L et al (1987) Expression of tartrate-resistant acid phosphatase in bone marrow macrophages. Basic Appl Histochem 31: 433-440.
37. Chen HL, Demiralp B, Schneider A et al (2002) Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277: 19374-19381.
38. Jackson R, Kumarasuriyar A, Nurcombe V et al (2006) Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells. J Cell Physiol 209: 894-904.
39. Wang Y, Liu Y, Rowe D (2007) Effects of transient PTH on early proliferation, apoptosis, and subsequent differentiation of osteoblasts in primary osteoblast cultures. Am J Physiol Endocrinol Metab 292: E594-E603.
40. Uchiyama M, Nakamichi Y, Nakamura M et al (2009) Dental pulp and periodontal ligament cells support osteoclastic differentiation. J Dent Res 88: 609-614.
41. Onyia JE, Miles RR, Yang X et al (2000) In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J Bone Miner Res 15: 863-871.
42. Dempster D, Hughes-Begos C, Plavetic-Chee K et al (2005) Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J Cell Biochem 95: 139-148.
43. Isogai Y, Akatsu T, Ishizuya T et al (1996) Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11: 1384-1393.
44. Schwartz Z, Semba S, Graves D et al (1997) Rapid and long-term effects of PTH(1-34) on growth plate chondrocytes are mediated through two different pathways in a cell-maturation-dependent manner. Bone 21: 249-259.
45. Leibbrandt A, Penninger JM (2009) RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. Adv Exp Med Biol 649: 100-113.
46. Wright HL, McCarthy HS, Middleton J et al (2009) RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med 2: 56-64.
47. Kobayashi Y, Udagawa N, Takahashi N (2009) Action of RANKL and OPG for osteoclastogenesis. Crit Rev Eukaryot Gene Expr 19: 61-72.
48. Tsuji K, Uno K, Zhang GX et al (2004) Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Miner Metab 22: 94-103.
49. Kim T, Handa A, Iida J et al (2007) RANKL expression in rat periodontal ligament subjected to a continuous orthodontic force. Arch Oral Biol 52: 244-250.
50. Taubman MA, Kawai T, Han X (2007) The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol 34: 367-369.
51. Lossdorfer S, Gotz W, Rath-Deschner B et al (2006) Parathyroid hormone(1-34) mediates proliferative and apoptotic signaling in human periodontal ligament cells in vitro via protein kinase C-dependent and protein kinase A-dependent pathways. Cell Tissue Res 325: 469-479.
52. Nohutcu RM, McCauley LK, Koh AJ et al (1997) Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro. J Periodontol 68: 320-327.